🔎 Trials Near Me

Dachaigh › Carcinoma Urothelial (Cealla Transitional) › Virginia › Charlottesville

Sgrùdaidhean clionaigeach Carcinoma Urothelial (Cealla Transitional) ann an Charlottesville, VA

Tha 5 sgrùdaidhean airson Carcinoma Urothelial (Cealla Transitional) a’ lorg phàirtichean aig làraichean ann agus timcheall air Charlottesville (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

A’ fastadhÌre 1
  • Exelixis Clinical Site #66, Charlottesville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT05176483

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

A’ fastadhÌre 3
  • University of Virginia Comprehensive Cancer Center, Charlottesville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06774131

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

A’ fastadhÌre 1
  • The University of Virgina, Charlottesville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Ògmh 2026 · NCT07484022

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, Charlottesville
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

A Study of NX-1607 in Adults With Advanced Malignancies

A’ fastadhÌre 1
  • University of Virginia, Charlottesville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2025 · NCT05107674

Sgrùdaidhean Carcinoma Urothelial (Cealla Transitional) ann am bailtean eile

Sgrùdaidhean eile ann an Charlottesville

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.